Back to search

Netherlands· NL-6aafb344df7c

Cystagon, capsules 150 mg

A mercaptamine product containing mercaptaminewaterstoftartraat + siliciumdioxide (e 551), registered in Netherlands by Orphan Europe SARL. The same ATC class is registered in 14 of our 19 countries.

ATC A16AA04

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedCystagon, capsules 150 mgATCA16AA04REGISTER NO.NL-6aafb344df7cPACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Mercaptamine is registered in 14 of 19 countries.

Countries holding a registration under ATC A16AA04 (mercaptamine), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 8 of them publish a price we can compare per daily dose

Mercaptamine · ATC A16AA04

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of mercaptamine costs, country by country.

Normalised to the WHO defined daily dose (2 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Mercaptamine · price per daily dose (2 g)

USD · FX 28 Sept 2026

  • CH Switzerland$589.95
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
MERCAPTAMINEWATERSTOFTARTRAAT + SILICIUMDIOXIDE (E 551)
Manufacturer
Orphan Europe SARL
Country
Netherlands (NL)
ATC code
A16AA04
ATC class
Mercaptamine
Defined daily dose
2 g, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/97/039

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c964f410-b7f8-41bd-b288-9fa877b683d2
GET /v1/drugs/c964f410-b7f8-41bd-b288-9fa877b683d2?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, hard",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/cystagon-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Mercaptamine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp70068",
  "excipients": [
    "AMMONIA (E 527)",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "GELATINE (E 441)",
    "IJZEROXIDE ZWART (E 172)",
    "MAGNESIUMSTEARAAT (E 470b)",
    "NATRIUMLAURILSULFAAT",
    "PROPYLEENGLYCOL (E 1520)",
    "SCHELLAK GLAZE, GEDEELTELIJK VERESTERD",
    "TITAANDIOXIDE (E 171)",
    "ZETMEEL, GEPREGELATINEERD",
    "ZWARTE INKT"
  ],
  "substances": [
    "MERCAPTAMINEWATERSTOFTARTRAAT",
    "SILICIUMDIOXIDE (E 551)"
  ],
  "leaflet_url": null,
  "authorised_at": "1997/06/23",
  "procedure_number": "EMEA/H/C/000125",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/97/039",
  "additional_monitoring": "N"
}

See everything about mercaptamine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.